Ardelyx, Inc. Share Price

Ardelyx, Inc. Share Price

NASDAQ: ARDX | Small Cap
$3.10
+$0.02 (0.49%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Ardelyx, Inc. Stock Performance

Open
$3.12
Prev. Close
$3.08
Circuit Range
N/A
Day Range
$3.08 - $3.15
Year Range
$2.96 - $8.39
Volume
1,40,704
Average Traded
$3.10

Ardelyx, Inc. Share Price Today

As of 30 October 2026, Ardelyx, Inc.'s share price is $3.10. The stock opened at $3.12, compared to its previous close of $3.08. During today's trading session, Ardelyx, Inc.'s share price traded between $3.08 and $3.15, with an average price of $3.12. Over the past 52 weeks, the stock has recorded a high of $8.39 and a low of $2.96. In terms of performance, Ardelyx, Inc.'s share price has declined by 50.95% over the last six months and is down 48.84% on a year-on-year basis.

Ardelyx, Inc. Share Price Chart

Line chart of the Ardelyx, Inc. price trend over the selected period. The price rose overall, ranging from 3.08 to 3.16, ending at 3.10.
$3.08$3.15
L
Show Current Price
H

Ardelyx, Inc. Stock Fundamentals & Key Indicators

Market Cap
$747.20M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.22
Revenue (TTM)
$407.32B
Return On Equity (TTM)
-37.38%
Profit Margin
-15.12%
Debt to Equity
1.69
Quarterly Earnings Growth YoY
-1623.71%

Ardelyx, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$110.33$125.22$94.47$120.88
Net Profit-$0.97-$0.41-$37.61-$16.72
Net Profit Margin-0.88%-0.33%-39.81%-13.83%
Income ChangeN/A57.73%-9073.17%55.54%

Ardelyx, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$52.16$124.46$333.62$407.32
Net Profit-$67.21-$66.07-$39.14-$61.60
Net Profit Margin-128.85%-53.09%-11.73%-15.12%
Income ChangeN/A1.70%40.76%-57.38%

About Ardelyx, Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Ardelyx, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.40
$3.10
-9.37%
Sep 2026
$3.78
$3.42
-10.48%
Aug 2026
$4.98
$3.81
-23.01%
Jul 2026
$5.11
$4.96
-3.03%
Jun 2026
$5.96
$5.11
-15.26%
May 2026
$6.18
$6.03
-4.59%
Apr 2026
$6.04
$6.32
+5.51%
Mar 2026
$6.26
$5.99
-8.41%
Feb 2026
$7.73
$6.54
-15.06%
Jan 2026
$5.83
$7.70
+32.08%
Dec 2025
$5.82
$5.83
+0.17%
Nov 2025
$6.07
$5.82
-3.96%

ARDX Share Price FAQs